LT4007B - Composition to prevent seasickness - Google Patents

Composition to prevent seasickness Download PDF

Info

Publication number
LT4007B
LT4007B LTIP1849A LTIP1849A LT4007B LT 4007 B LT4007 B LT 4007B LT IP1849 A LTIP1849 A LT IP1849A LT IP1849 A LTIP1849 A LT IP1849A LT 4007 B LT4007 B LT 4007B
Authority
LT
Lithuania
Prior art keywords
composition
symptoms
methyl
transport
preparation
Prior art date
Application number
LTIP1849A
Other languages
English (en)
Lithuanian (lt)
Inventor
Gyorgy Bodo
Jozsef Knoll
Eva Somfai
Sandor Virag
Ferenc Zak
Original Assignee
Chinoin Gyogyszer Es Vegyeszet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chinoin Gyogyszer Es Vegyeszet filed Critical Chinoin Gyogyszer Es Vegyeszet
Publication of LTIP1849A publication Critical patent/LTIP1849A/xx
Publication of LT4007B publication Critical patent/LT4007B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Anesthesiology (AREA)
  • Otolaryngology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Lubricants (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Confectionery (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Detergent Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Optical Integrated Circuits (AREA)
  • Transplanting Machines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steam Or Hot-Water Central Heating Systems (AREA)
  • Securing Of Glass Panes Or The Like (AREA)
  • Dental Preparations (AREA)
  • Connection Of Batteries Or Terminals (AREA)
LTIP1849A 1986-12-19 1994-01-31 Composition to prevent seasickness LT4007B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU865338A HU197510B (en) 1986-12-19 1986-12-19 Process for producing pharmaceutical composition containing phenyl-alkyl-amine derivatives, against motion-sick

Publications (2)

Publication Number Publication Date
LTIP1849A LTIP1849A (en) 1995-08-25
LT4007B true LT4007B (en) 1996-07-25

Family

ID=10970131

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP1849A LT4007B (en) 1986-12-19 1994-01-31 Composition to prevent seasickness

Country Status (26)

Country Link
US (1) US4925878A (ro)
EP (1) EP0294441B1 (ro)
JP (1) JP2534553B2 (ro)
AT (1) ATE82847T1 (ro)
BG (1) BG51918A1 (ro)
CY (1) CY1740A (ro)
CZ (1) CZ277831B6 (ro)
DD (1) DD264851A5 (ro)
DE (1) DE3782935T2 (ro)
DK (1) DK464788D0 (ro)
ES (1) ES2009228A6 (ro)
FI (1) FI883837A7 (ro)
GE (1) GEP19970949B (ro)
GR (1) GR871953B (ro)
HK (1) HK105193A (ro)
HU (1) HU197510B (ro)
IL (1) IL84786A (ro)
LT (1) LT4007B (ro)
LV (1) LV10185B (ro)
MD (1) MD408C2 (ro)
MX (1) MX9203088A (ro)
PT (1) PT86406B (ro)
RU (1) RU1825314C (ro)
SK (1) SK278500B6 (ro)
UA (1) UA19281A1 (ro)
WO (1) WO1988004552A1 (ro)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861800A (en) * 1987-08-18 1989-08-29 Buyske Donald A Method for administering the drug deprenyl so as to minimize the danger of side effects
CS269271B1 (en) * 1988-05-30 1990-04-11 Hajicek Josef Method of selegiline's hydrochloride production
HU208484B (en) * 1988-08-17 1993-11-29 Chinoin Gyogyszer Es Vegyeszet Process for producing pharmaceutical composition containing acid additional salt of selegilin as active component for treating schisofrenia
US5744500A (en) 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5767164A (en) * 1991-04-04 1998-06-16 Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5444095A (en) * 1991-04-04 1995-08-22 University Of Toronto, Innovations Foundation Use of deprenyl to rescue damaged nerve cells
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
JPH06506204A (ja) * 1991-04-04 1994-07-14 ザ・ユニバーシティ・オブ・トロント・イノベイションズ・ファウンデイション 神経細胞機能を維持し、喪失を防止し、または回復させるためのデプレニールの使用
HUT63579A (en) * 1991-12-20 1993-09-28 Chinoin Gyogyszer Es Vegyeszet Process for producing double-phase pharmaceutical compositions suitable for treating diseases occurring during neurodegenerative processes
US5242950A (en) * 1992-04-23 1993-09-07 Somerset Pharmaceuticals, Inc. Treatment of macular degeneration
US5817336A (en) * 1993-04-02 1998-10-06 Orion-Yhtyma Oy Composition containing selegiline
FR2704756B1 (fr) * 1993-05-04 1995-07-28 Sanofi Elf Utilisation de la sélégiline en médecine vétérinaire.
US5547995B1 (en) * 1993-05-04 1998-01-27 Sanofi Elf Use of selegiline in veterinary medicine
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
DK0762877T3 (da) * 1994-06-03 2001-07-16 Thejmde Trust Meta-substituerede arylalkylaminer og terapeutiske og diagnostiske anvendelser deraf
US6319954B1 (en) 1995-01-13 2001-11-20 Somerset Pharmaceuticals, Inc. S-(+)-desmethylselegiline and its use in the therapeutic methods and pharmaceutical compositions
US6033682A (en) 1995-01-13 2000-03-07 Somerset Pharmaceuticals, Inc. S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
US6348208B1 (en) 1995-01-13 2002-02-19 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
US6299901B1 (en) 1995-01-13 2001-10-09 Somerset Pharmaceuticals, Inc. Methods and pharmaceutical compositions employing desmethylselegiline
WO1996024346A1 (en) 1995-02-10 1996-08-15 The University Of Toronto Innovations Foundation Deprenyl compounds for treatment of glaucoma
JP3273141B2 (ja) * 1995-03-02 2002-04-08 アール． ピー． シェーラー リミテッド モノアミンオキシダーゼｂインヒビターからなる医薬組成物
DE19716905C1 (de) * 1997-04-22 1998-08-27 Iip Inst Fuer Ind Pharmazie Fo Stabile, wäßrige Lösung auf der Grundlage von Selegilin und Vorrichtung zu ihrer Verabreichung
US6042533A (en) * 1998-07-24 2000-03-28 Kania; Bruce Apparatus and method for relieving motion sickness
US6197329B1 (en) 1999-05-03 2001-03-06 Drugtech Corporation Anti-nausea compositions and methods
US6443913B1 (en) 2000-03-07 2002-09-03 Bruce Kania Apparatus and method for relieving motion sickness
US6497649B2 (en) * 2001-01-21 2002-12-24 University Of Washington Alleviating motion, simulator, and virtual environmental sickness by presenting visual scene components matched to inner ear vestibular sensations
US7128705B2 (en) * 2002-11-26 2006-10-31 Artis Llc Motion-coupled visual environment for prevention or reduction of motion sickness and simulator/virtual environment sickness
AT16235U1 (de) * 2018-06-21 2019-04-15 Dr Reinhart Jarisch Kaugummi enthaltend Vitamin C

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212484B (en) 1992-04-10 1996-07-29 Schott Glaswerke Lead-and bariumless crystalline glass with high light transmission

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1227447B (de) * 1962-03-30 1966-10-27 Chinoin Gyogyszer Es Vegyeszet Verfahren zur Herstellung von Phenylisopropylaminen
GB1031425A (en) * 1962-03-30 1966-06-02 Chinoin Gyogyszer Es Vegyeszet New aralkylamines and their preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU212484B (en) 1992-04-10 1996-07-29 Schott Glaswerke Lead-and bariumless crystalline glass with high light transmission

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NO AUTHORS LISTED: "EVALUATION of drugs for protection against motion sickness aboard transport ships; report of study by Army, Navy, Air Force motion sickness team", J AM MED ASSOC., 1956, pages 755 - 760

Also Published As

Publication number Publication date
FI883837L (fi) 1988-08-18
DE3782935T2 (de) 1993-04-08
HU197510B (en) 1989-04-28
JPH01501626A (ja) 1989-06-08
MD408C2 (ro) 1996-07-31
RU1825314C (ru) 1993-06-30
IL84786A (en) 1991-08-16
LTIP1849A (en) 1995-08-25
SK278500B6 (en) 1997-07-09
DD264851A5 (de) 1989-02-15
LV10185B (en) 1995-04-20
EP0294441B1 (en) 1992-12-02
WO1988004552A1 (en) 1988-06-30
HUT45196A (en) 1988-06-28
HK105193A (en) 1993-10-15
BG51918A1 (en) 1993-11-15
ATE82847T1 (de) 1992-12-15
CZ277831B6 (en) 1993-06-16
PT86406B (pt) 1990-11-20
GR871953B (en) 1988-04-19
CY1740A (en) 1995-10-20
JP2534553B2 (ja) 1996-09-18
GEP19970949B (en) 1997-03-31
EP0294441A1 (en) 1988-12-14
FI883837A0 (fi) 1988-08-18
MX9203088A (es) 1992-07-01
PT86406A (en) 1988-01-01
ES2009228A6 (es) 1989-09-16
FI883837A7 (fi) 1988-08-18
CS8709491A1 (en) 1990-05-14
LV10185A (lv) 1994-10-20
UA19281A1 (uk) 1997-12-25
DK464788A (da) 1988-08-18
US4925878A (en) 1990-05-15
DK464788D0 (da) 1988-08-18
DE3782935D1 (de) 1993-01-14

Similar Documents

Publication Publication Date Title
LT4007B (en) Composition to prevent seasickness
DE68926169T2 (de) Heilmittel enthaltende matrize
DE3650488T2 (de) Verwendung eines Tetrahydrocarbazolonderivates zur Herstellung von Arzneimitteln
DE60131004T2 (de) Pharmazeutische zubereitungen gegen kopfschmerz, migräne, nausea und erbrechen
US11839600B2 (en) Neurodevelopmental disorder therapy
DE69926804T2 (de) Vorrichtungen zur behandlung und diagnose des restless leg syndroms
Towse Cinnarizine—a labyrinthine sedative
DE3782028T2 (de) Verwendung von ketonderivaten zur behandlung von bewusstseinsstoerungen.
DE60011650T2 (de) Synergistische kombination von nk1-rezeptor antagonisten und gaba analogen
DE69131398T2 (de) Verwendung von 5-ht4 rezeptorantagonisten zur behandlung von vorhof-fibrillation und zur vorbeugung von schlaganfall
Schittecatte et al. Reduced clonidine rapid eye movement sleep suppression in patients with primary major affective illness
DE60217653T2 (de) Verwendung von Melatonin zur Behandlung von Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom
Ekeberg et al. Effects of β1‐and β2‐blockade on blood pressure and sympathetic responses to flight phobia stress
DE69122480T2 (de) Verwendung von Phenyläthanolaminotetralinen zur Herstellung eines antidepressiven und Antistress-Arzneimittels
DE2831728C2 (de) Arzneimittel zur Behandlung von Kopfschmerzen
DE3505743A1 (de) Bromocriptin enthaltende zusammensetzungen
HK40083948A (en) A2-73 for treating angelman syndrome, williams syndrome smith-magenis syndrome and multiple sclerosis
EP0192098A2 (de) Verwendung des 2-Amino-6-allyl-5,6,7,8-tetrahydro-4H-thiazolo[4,5-d]azepins zur Herstellung eines zur Behandlung der Parkinsonschen Erkrankung bzw. des Parkinsonismus geeigneten Arzneimittels
Sebban et al. Dexfenfluramine profile in quantitative EEG and its topographical aspects
Wessely 111. Migräne
Hussain Benzhexol-induced hallucinosis
STATURE clinical Rounds
DE3507861A1 (de) Mittel zur behandlung der parkinsonschen-erkrankung bzw. des parkinsonismus
HK1155659B (en) Pharmaceutical composition for treatment of fibromyalgia
TH41275B (th) สารแขวนลอยที่มีน้ำของ 9-ไฮดรอกซิริสเพอริโดนแฟททีแอซิดเอสเทอร์

Legal Events

Date Code Title Description
MM9A Lapsed patents

Effective date: 19980131